Domínguez-Muñoz, Juan Enrique
Nieto-Garcia, Laura
López-Díaz, Javier
Lariño-Noia, Jose
Abdulkader, Ihab
Iglesias-Garcia, Julio
Funding for this research was provided by:
Abbott Products Operations, Allschwil, Switzerland
Article History
Received: 20 September 2017
Accepted: 26 April 2018
First Online: 5 May 2018
Authors’ information
: J.E.D.-M. is expert pancreatologist, Director of the Department of Gastroenterology and Hepatology and Professor of Medicine at the University Hospital of Santiago de Compostela, Spain. J.L.-N. and J.I.-G. are experts endosonographers and clinical pancreatologists. I.A. is an expert cytopathologist for EUS-guided FNA-FNB samples of pancreatic lesions.
: The study was conducted in accordance with the Declaration of Helsinki and its amendments, and with Good Clinical Practice guidelines. Ethical approval for this study was obtained from the Ethics and Clinical Research Committee of Santiago de Compostela-Lugo, Spain. The need for consent for this study was waived by the institutional review board (Ethics and Clinical Research Committee of Santiago de Compostela-Lugo, Span) due to its retrospective design.
: J.E.D.-M. has worked as advisor and speaker for Mylan and Abbott. J.L.-N. and J.I.-G. have worked as speaker for Mylan and Abbott. The remaining authors declare that they have nothing to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.